What ImmunityBio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 2 | 16 |
| Total trades | 3 | 51 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 55,979 | 6,102,322 |
| Disposed | 106,056 | 1,544,030 |
| Net activity | −50,077 | +4,558,292 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Simon Barry J. | Director | Oct 05 | Disclosed 10b5-1 sale · S | −25,000 | $10.75 | −$269K | 2,777,788 |
| Cohen Cheryl | Director | Oct 02 | Open-market sale · S | −81,056 | $10.50 | −$851K | 100,309 |
| Cohen Cheryl | Director | Oct 02 | Exercise / conversion · M | +55,979 | $2.98 | +$167K | 181,365 |
| Cohen Cheryl | Director | Jul 02 | Open-market sale · S | −131,210 | $9.50 | −$1.25M | 125,386 |
| Cohen Cheryl | Director | Jul 02 | Exercise / conversion · M | +55,979 | $2.98 | +$167K | 256,596 |
| Selecky Christobel | Director | Jul 01 | Disclosed 10b5-1 sale · S | −159,478 | $9.02 | −$1.44M | 0 |
| Selecky Christobel | Director | Jul 01 | Exercise / conversion · M | +124,414 | $2.99 | +$372K | 159,478 |
| Selecky Christobel | Director | Jul 01 | Exercise / conversion · M | +35,064 | $2.98 | +$104K | 35,064 |
| Selecky Christobel | Director | Jun 30 | Disclosed 10b5-1 sale · S | −1,000 | $9.00 | −$9K | 0 |
| Selecky Christobel | Director | Jun 30 | Exercise / conversion · M | +300 | $2.99 | +$897 | 1,000 |
| Selecky Christobel | Director | Jun 30 | Exercise / conversion · M | +700 | $2.98 | +$2.09K | 700 |
| Selecky Christobel | Director | Jun 29 | Disclosed 10b5-1 sale · S | −95,722 | $9.01 | −$862K | 0 |
| Selecky Christobel | Director | Jun 29 | Exercise / conversion · M | +30,000 | $2.84 | +$85.2K | 95,722 |
| Selecky Christobel | Director | Jun 29 | Exercise / conversion · M | +33,549 | $2.99 | +$100K | 65,722 |
| Selecky Christobel | Director | Jun 29 | Exercise / conversion · M | +32,173 | $2.98 | +$95.9K | 32,173 |
| Simon Barry J. | Director | Jun 24 | Disclosed 10b5-1 sale · S | −25,000 | $7.88 | −$197K | 2,802,788 |
| Simon Barry J. | Director | Jun 04 | Disclosed 10b5-1 sale · S | −23,033 | $7.18 | −$165K | 2,827,788 |
| Soon Shiong Patrick | See remarks | Mar 31 | Derivative Conversion · C | +4,606,596 | $5.43 | +$25M | 251,018,873 |
| Simon Barry J. | Director | Feb 24 | Disclosed 10b5-1 sale · S | −75,000 | $12.01 | −$901K | 2,850,821 |
| Simon Barry J. | Director | Feb 23 | Disclosed 10b5-1 sale · S | −165,000 | $10.25 | −$1.69M | 2,925,821 |
Loading...
